Richard Carvajal on Multidisciplinary Approach to Managing Immunotherapy Toxicities
Richard Carvajal, MD, discusses the importance of a multidisciplinary approach when monitoring patients for immunotherapy toxicities.
Richard Carvajal, MD, Columbia University Medical Center, discusses the importance of a multidisciplinary approach when monitoring patients for immunotherapy toxicities.
Nursing staff are vital when it comes to follow-up with patients on immunotherapy treatments. Daily phone calls may even be necessary to ensure that patients are monitored as needed. For combination immunotherapy treatments, Carvajal suggests using the wisdom seen in the single agents. Staff must be hypervigilant and there must be standards developed for follow-up and management of these patients.
Stopping ICIs at 1 or 2 Years May Not Compromise Survival in HNSCC
September 11th 2024This retrospective, population-based study shows strong efficacy across multiple patient subgroups and different lines of therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma.
